Notes And Other Explanatory Information [Abstract]

ERYTECH Pharma S.A. - Filing #2813524

Concept	2022-01-01 to 2022-12-31
Notes and other explanatory information [abstract]
Disclosure of accounting judgements and estimates [text block]	Recours à des estimations et jugements
Disclosure of auditors' remuneration [text block]	HONORAIRES DES COMMISSAIRES AUX COMPTES
Disclosure of authorisation of financial statements [text block]
Disclosure of basis of preparation of financial statements [text block]	Base de préparation
Disclosure of borrowings [text block]
Disclosure of cash and cash equivalents [text block]	Trésorerie et équivalents de trésorerie
Disclosure of changes in accounting policies, accounting estimates and errors [text block]	Déclaration de conformité
Disclosure of commitments and contingent liabilities [text block]
Disclosure of credit risk [text block]
Disclosure of debt instruments [text block]	Dettes financières
Disclosure of depreciation and amortisation expense [text block]	Dotation aux amortissements, dépréciations et provisions
Disclosure of derivative financial instruments [text block]	Obligations convertibles
Disclosure of earnings per share [text block]	Résultat de base par action et résultat dilué par action
Disclosure of employee benefits [text block]	Charges de personnel
Disclosure of entity's operating segments [text block]	Information sectorielle
Disclosure of events after reporting period [text block]	Événements postérieurs à la clôture
Disclosure of expenses by nature [text block]	Charges opérationnelles par nature
Disclosure of fair value measurement [text block]
Disclosure of fair value of financial instruments [text block]
Disclosure of finance income (cost) [text block]	Résultat financier
Disclosure of finance income [text block]
Disclosure of financial risk management [text block]	GESTION DES RISQUES FINANCIERS
Disclosure of general and administrative expense [text block]	Frais généraux et administratifs
Disclosure of general information about financial statements [text block]	Sauf indication contraire, tous les montants sont présentés en milliers d’euros.
Disclosure of going concern [text block]
Disclosure of impairment of assets [text block]
Disclosure of income tax [text block]	Impôt sur le résultat
Disclosure of information about key management personnel [text block]	PARTIES LIEES
Disclosure of intangible assets [text block]	Immobilisations incorporelles
Disclosure of issued capital [text block]	Capitaux propres
Disclosure of leases [text block]
Disclosure of liquidity risk [text block]
Disclosure of market risk [text block]
Disclosure of objectives, policies and processes for managing capital [text block]
Disclosure of other assets [text block]
Disclosure of other current assets [text block]
Disclosure of other liabilities [text block]
Disclosure of other operating income [text block]
Disclosure of other provisions, contingent liabilities and contingent assets [text block]	Provisions
Disclosure of property, plant and equipment [text block]
Disclosure of research and development expense [text block]	Frais de recherche et développement
Disclosure of reserves within equity [text block]
Disclosure of revenue [text block]	Produits des activités courantes
Disclosure of share-based payment arrangements [text block]	Paiement fondé sur des actions (IFRS 2)
Disclosure of subsidiaries [text block]	Principes de consolidation
Disclosure of tax receivables and payables [text block]
Disclosure of trade and other payables [text block]	Dettes fournisseurs et autres passifs courants
Disclosure of trade and other receivables [text block]	Créances client et autres actifs courants